Cargando…
Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria
Regular transfusion and chelation therapy produces increased life expectancy in thalassaemic patients who may develop new complications. Since few data are available regarding hypercalciuria in β‐thalassaemia major (TM), the aim of our study was to evaluate its prevalence, risk factors and clinical...
Autores principales: | Aliberti, Ludovica, Gagliardi, Irene, Gamberini, Maria Rita, Ziggiotto, Andrea, Verrienti, Martina, Carnevale, Aldo, Bondanelli, Marta, Zatelli, Maria Chiara, Ambrosio, Maria Rosaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542302/ https://www.ncbi.nlm.nih.gov/pubmed/35768889 http://dx.doi.org/10.1111/bjh.18345 |
Ejemplares similares
-
SLN124, a GalNac‐siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron‐overload in a mouse model of β‐thalassaemia
por: Vadolas, Jim, et al.
Publicado: (2021) -
Fluid overload due to intravenous fluid therapy for vaso‐occlusive crisis in sickle cell disease: incidence and risk factors
por: Gaartman, Aafke E., et al.
Publicado: (2021) -
Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data
por: Malinowski, A. Kinga, et al.
Publicado: (2021) -
Antithrombin‐III mitigates thrombin‐mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow
por: Wulftange, William J., et al.
Publicado: (2022) -
The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains
por: Early, Macy L., et al.
Publicado: (2022)